Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thyroid Cancer, Papillary × Celecoxib × Clear all

Sponsor

Conditions

Colorectal Neoplasms 9 Breast Neoplasms 9 Colonic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Rectal Neoplasms 4 Lung Neoplasms 4 Head and Neck Neoplasms 4 Adenomatous Polyposis Coli 4 Sarcoma 3 Glioblastoma 3 Central Nervous System Neoplasms 3 Paranasal Sinus Neoplasms 2 Neoplasms 2 Mouth Neoplasms 2 Melanoma 2 Laryngeal Neoplasms 2 Gliosarcoma 2 Breast Carcinoma In Situ 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Triple Negative Breast Neoplasms 1 Tobacco Use Disorder 1 Stomatitis 1 Smoldering Multiple Myeloma 1 Smoking 1 Recurrence 1 Prostatic Neoplasms 1 Prostatic Hyperplasia 1 Precancerous Conditions 1

Interventions

Magnetic Resonance Spectroscopy 5 lenvatinib 3 cabozantinib 3 Sunitinib 3 Iodine-131 3 trametinib 2 selpercatinib 2 dabrafenib 2 Sorafenib 2 Fluorodeoxyglucose F18 2 AZD 6244 2 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2 vandetanib 1 tremelimumab 1 tovorafenib 1 tanespimycin 1 romidepsin 1 pralsetinib 1 pembrolizumab 1 omipalisib 1 durvalumab 1 copanlisib 1 cediranib 1 alectinib 1 aflibercept 1 Vorinostat 1 Vemurafenib 1 Thyrotropin Alfa 1 Thyroidectomy 1 Thyroid (USP) 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡